Dian Wang

Dian Wang, MD, PhD, is a Professor in the Department of Radiation Oncology at Rush Medical College, Rush University, Chicago, IL. He practices at multiple locations including the RUSH MD Anderson Cancer Center and Rush Oak Park Hospital, providing advanced radiation therapy for various cancers.

• Institution: Rush University
• School: Rush Medical College
• Department: Department of Radiation Oncology
• Academic Rank: Professor
• Location: Chicago, IL

Education:

• Medical School: Tongji Medical College, China
• Residency: Ohio State University Wexner Medical Center, Columbus, Ohio

Dian Wang specializes in Radiation Oncology with clinical expertise in treating genitourinary cancers (prostate, bladder, testicular), head and neck tumors, soft tissue sarcomas, and lymphomas. He employs cutting-edge techniques such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), brachytherapy, and intraoperative radiation therapy (IORT) to improve treatment precision and outcomes. His research emphasizes reducing late toxicities, optimizing target volumes, and integrating modern radiotherapy with systemic agents.

The publication trends from 2011 to 2022 highlight a strong focus on soft tissue sarcomas, prostate cancer, and technological advancements in radiation delivery. His work includes clinical trials (e.g., RTOG-0630), consensus guidelines for target delineation, and reviews on combining targeted therapies with radiation. Key themes include toxicity reduction, adaptive radiotherapy, and stereotactic ablative techniques, reflecting a commitment to improving safety and efficacy in oncology care.

Scientific Awards:

• Castle Connolly Top Doctor (since 2013)

Dian Wang actively contributes to clinical research and education at Rush University, mentoring future oncologists and advancing evidence-based practices. His work spans clinical trials, protocol development, and interdisciplinary collaboration. He has been involved in Radiation Therapy Oncology Group (RTOG) studies and multi-institutional research aimed at refining radiation oncology standards. While specific grant details are not listed, his leadership in national trials indicates significant research funding and academic influence.

Dian Wang is affiliated with the Rush MD Anderson Cancer Center, a leading institution in cancer care and research, where he contributes to a multidisciplinary team delivering comprehensive radiation oncology services. His clinical and research activities are integrated within a robust academic medical environment focused on innovation and patient-centered care.